Biosenta Inc (ZRO.CX)
0.075
0.00 (0.00%)
CAD |
CNSX |
Nov 12, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 2.390M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -81.01% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 11.02 |
| Price to Book Value | -- |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | -0.7488 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | -- |
Profile
| Biosenta Inc is a Canada based company focused on producing and deploying anti-microbial products and remediation solutions to the marketplace for retail, institutional and industrial users. It is engaged in developing sales for its True product lines and the development for commercial applications of its technology to produce an antimicrobial Tri-Filler product. The company's anti-microbial products kill mold, bacteria, and fungi on contact and prevent re-growth. ZeroMold helps contractors to build mold-resistant buildings and provide consumers with a solution to their mold problem. The firm also manufactures and distributes a proprietary anti-microbial filler product for the industrial sector. |
| URL | https://www.biosenta.com |
| Investor Relations URL | http://www.biosenta.com/investors |
| HQ State/Province | Ontario |
| Sector | |
| Industry | |
| Equity Style | Small Cap/Value |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Ratings
Profile
| Biosenta Inc is a Canada based company focused on producing and deploying anti-microbial products and remediation solutions to the marketplace for retail, institutional and industrial users. It is engaged in developing sales for its True product lines and the development for commercial applications of its technology to produce an antimicrobial Tri-Filler product. The company's anti-microbial products kill mold, bacteria, and fungi on contact and prevent re-growth. ZeroMold helps contractors to build mold-resistant buildings and provide consumers with a solution to their mold problem. The firm also manufactures and distributes a proprietary anti-microbial filler product for the industrial sector. |
| URL | https://www.biosenta.com |
| Investor Relations URL | http://www.biosenta.com/investors |
| HQ State/Province | Ontario |
| Sector | |
| Industry | |
| Equity Style | Small Cap/Value |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |